Intraoperative Rupture of the Ovarian Capsule in Early-Stage Ovarian Cancer
Authors:
- 7 July 2021
- journal article
- review article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 138 (2) , 261-271
Abstract
OBJECTIVE: To examine the effects of intraoperative ovarian capsule rupture on progression-free survival and overall survival in women who are undergoing surgery for early-stage ovarian cancer. DATA SOURCES: MEDLINE using PubMed, EMBASE (Elsevier), ClinicalTrials.gov, and Scopus (Elsevier) were searched from inception until August 11, 2020. METHODS OF STUDY SELECTION: High-quality studies reporting survival outcomes comparing ovarian capsule rupture to no capsule rupture among patients with early-stage epithelial ovarian cancer who underwent surgical management were abstracted. Study quality was assessed with the Newcastle-Ottawa Scale, and studies with scores of at least 7 points were included. TABULATION, INTEGRATION, AND RESULTS: The data were extracted independently by multiple observers. Random-effects models were used to pool associations and to analyze the association between ovarian capsule rupture and oncologic outcomes. Seventeen studies met all the criteria for inclusion in the meta-analysis. Twelve thousand seven hundred fifty-six (62.6%) patients did not have capsule rupture and had disease confined to the ovary on final pathology; 5,532 (33.7%) patients had intraoperative capsule rupture of an otherwise early-stage ovarian cancer. Patients with intraoperative capsule rupture had worse progression-free survival (hazard ratio [HR] 1.92, 95% CI 1.34–2.76, P<.001), with moderate heterogeneity (I2=41%, P=.07) when compared with those without capsule rupture. Pooled results from these studies showed a worse overall survival (HR 1.48, 95% CI 1.15–1.91, P=.003), with moderate heterogeneity (I2=53%, P=.02) when compared with patients without intraoperative capsule rupture. This remained significant in a series of sensitivity analyses. CONCLUSION: This systematic review and meta-analysis of high-quality observational studies shows that intraoperative ovarian capsule rupture results in decreased progression-free survival and overall survival in women with early-stage ovarian cancer who are undergoing initial surgical management. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42021216561.Keywords
This publication has 48 references indexed in Scilit:
- Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor ruptureJournal of Gynecologic Oncology, 2013
- Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgeryGynecologic Oncology, 2011
- A study of cyst rupture rate by tissue type in open vs. laparoscopic surgery for ovarian tumorGynecological Surgery, 2011
- Recent advances in the biomarkers for epithelial ovarian cancerJournal of Gynecologic Oncology, 2011
- Prognostic Factors for Stage I Ovarian CarcinomaInternational Journal of Gynecological Pathology, 2010
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Long-Term Prognosis of Stage I Ovarian CarcinomaOncology, 2003
- FIGO staging classifications and clinical practice gudelines in the management of gynecologic cancersInternational Journal of Gynecology & Obstetrics, 2000
- Complete resection of adnexal masses with endobag extraction: the risk of involuntary tumour ruptureGynaecological Endoscopy, 2000
- Multivariate analysis of prognostic factors in patients with ovarian cancer stage I and IIInternational Journal of Gynecology & Obstetrics, 1997